Research extended

ELAN Corporation and Eli Lilly and company have extended their research programme into Alzheimer's disease until August 1998

ELAN Corporation and Eli Lilly and company have extended their research programme into Alzheimer's disease until August 1998. They have already made significant contributions" to the scientific understanding of the biological processes under which amyloid plaque forms in the Alzheimer brain, according to Elan.

  • Join The Irish Times on WhatsApp and stay up to date

  • Sign up to the Business Today newsletter for the latest new and commentary in your inbox

  • Listen to Inside Business podcast for a look at business and economics from an Irish perspective